Concepedia

Publication | Open Access

Randomized Trial of TAS-102 for Refractory Metastatic Colorectal Cancer

DOIFull Paper Access

1.4K

Citations

20

References

2015

Year

Robert J. Mayer, Eric Van Cutsem, Alfredo Falcone, Takayuki Yoshino, Rocio García‐Carbonero, Nobuyuki Mizunuma, Kentaro Yamazaki, Yasuhiro Shimada, Josep Tabernero, Yoshito Komatsu,
New England Journal of Medicine

Abstract

In patients with refractory colorectal cancer, TAS-102, as compared with placebo, was associated with a significant improvement in overall survival. (Funded by Taiho Oncology-Taiho Pharmaceutical; RECOURSE ClinicalTrials.gov number, NCT01607957.).

References

YearCitations

Page 1